41-1
41st Parliament,
1st Session
(June 2, 2011 - September 13, 2013)
Select a different session
Meeting Detail
Study on prescription pharmaceuticals in Canada
Topic:
Witnesses
- Kimby Barton, Director, Bureau of Cardiology, Allergy and neurological sciences, TPD (Health Canada)
- Dr. Alain Beaudet, President (Canadian Institutes of Health Research)
- Dr. Robert Peterson, Executive Director (Drug Safety and Effectiveness Network)
- Barbara Sabourin, Director General, Therapeutic Products Directorate (TPD) (Health Canada)
- Dr. John Patrick Stewart, A/Director General, Clinical Trials Office, TPD (Health Canada)
Meeting with interpretation and transcription